Skip to main content Deutsch

Karoline Gleixner

Assoc.-Prof.in PD Dr.in Karoline Gleixner

T: +43 (0)1 40400-44640
F: +43 (0)1 40400-40300
Email: karoline.gleixner@meduniwien.ac.at

Career:

  • 2000 - 2006: Studied human medicine at the Medical University of Vienna
  • 2004 - present: Research work at the Department of Hematology and Hemostaseology at the Medical University of Vienna (basic research, translational research and clinical research). Focus: myeloid neoplasms (AML, CML, mastocytosis)
  • 2006: Doctoral degree (Dr. med. Univ.) at the Medical University of Vienna
  • 2007 - 2013: Training as a specialist in internal medicine
  • 2013 - 2016: Additional specialization in haematology and internal oncology  
  • 2013: Habilitation at the Medical University of Vienna
  • 2014 - 2015: Senior physician/lecturer at the University Clinic Krems (KLPU)
  • 2015 - 2016: Basic research at the University Hospital (RWTH) Aachen, Germany (Institute for Biomedical Engineering - Cell Biology)
  • 2017 - current: Senior Physician and Associate Professor at the Department of Hematology and Hemostaseology at the Medical University of Vienna

Awards/Scholarships:

  • 2014: Funding grant der Österreichischen Gesellschaft für Hämatologie und Onkologie  (ÖGHO)
  • Hans und Blanca Moser Förderungspreis 2013
  • Researcher of the month der Medizinischen Universität Wien  05/2012
  • Denk Preis der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) 2010
  • Türk Preis der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) 2006

Functions/memberships:

  • Membership in the ÖGHO

Reviewer: in scientific journals:

  • Reviewer for Blood, Hematologica, Leukemia, Leukemia Research, BJH, ...

Qualifications:

  • Specialist in internal medicine
  • Additional specialist in hematology and internal oncology
  • Habilitation (internal medicine)

Focus on clinical research:

  • Acute myeloid leukemia (focus on secondary AML)
  • Chronic myelomonocytic leukemia (CMML)
  • Myelodysplastic syndromes
  • Indolent and aggressive systemic mastocytosis
  • Chronic myeloid leukemia

Focus on basic research:

  • Mastocytosis
  • Chronic myeloid leukemia
  • Acute myeloid leukemia (focus on secondary AML)
  • Chronic myelomonocytic leukemia (CMML)
  • New therapeutic targets
  • Targeted therapies
  • iPSC technology

Membership in the following societies:

  • Austrian Society for Hematology and Oncology
  • Austrian Society for Internal Medicine
  • EHA

Awards/Honors/Scholarships:

  • 2006: Türk Award der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO)
  • 2010: Denk Award der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO)
  • 2013: Hans und Blanca Moser Funding grant
  • 2014: Funding grant der Österreichischen Gesellschaft für Hämatologie und Onkologie  (ÖGHO)

Publications:

PubMed Publication list